HU-345
 | |
| Systematic (IUPAC) name | |
|---|---|
|
6,6,9-trimethyl-3-pentyl-1H-benzo[c]chromene-1,4(6H)-dione | |
| Identifiers | |
| PubChem | CID 11198119 |
| ChemSpider |
9373188  |
| ChEMBL |
CHEMBL127671 |
| Chemical data | |
| Formula | C21H24O3 |
| Molar mass | 324.414 g/mol |
| |
| |
| (verify) | |
HU-345 (cannabinol quinone) is a drug that is able to inhibit aortic ring angiogenesis more potently than its parent compound cannabinol.[1][2]
See also
References
- ↑ Natalya M. Kogan; et al. (2006). "A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells". Molecular Pharmacology 70 (1): 51–59. doi:10.1124/mol.105.021089. PMID 16571653.
- ↑ US patent 0092584, Mechoulam R, Kogan NM, Rabinowitz R, Schlesinger M, "Therapeutic Use of Quinonoid Derivatives of Cannabinoids", granted 2011-04-21
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.